Buminate 25%


Indications and Reactions:

Role Indications Reactions
Primary
Prophylaxis 36.1%
Drug Use For Unknown Indication 19.9%
Product Used For Unknown Indication 14.5%
Hypoalbuminaemia 7.2%
Hypovolaemia 4.2%
Oedema 2.4%
Acute Myeloid Leukaemia 1.2%
Ascites 1.2%
Blood Albumin Decreased 1.2%
Cerebral Haemorrhage 1.2%
Exchange Blood Transfusion 1.2%
Hepatic Cirrhosis 1.2%
Nephrotic Syndrome 1.2%
Polyuria 1.2%
Post Procedural Haemorrhage 1.2%
Prostate Cancer 1.2%
Protein Total Decreased 1.2%
Thrombosis Prophylaxis 1.2%
Anaemia 0.6%
Bronchopneumonia 0.6%
Pulmonary Oedema 25.2%
Myocardial Infarction 13.5%
Troponin Increased 9.9%
Atrial Fibrillation 9.0%
Hyperthermia 6.3%
Paralysis 5.4%
Hepatitis C Rna Positive 4.5%
Tachycardia 4.5%
Hypotension 2.7%
Wheezing 2.7%
Wrong Technique In Drug Usage Process 2.7%
Death 1.8%
Hyperhidrosis 1.8%
Hypersensitivity 1.8%
Meningitis 1.8%
Respiratory Distress 1.8%
Shock 1.8%
Blood Beta-d-glucan Increased 0.9%
Blood Pressure Fluctuation 0.9%
C-reactive Protein Increased 0.9%
Secondary
Drug Use For Unknown Indication 28.6%
Hypoalbuminaemia 21.0%
Product Used For Unknown Indication 14.3%
Nephrotic Syndrome 13.3%
Hypovolaemia 5.7%
Blood Albumin Decreased 3.8%
Acute Myeloid Leukaemia 1.9%
Ascites 1.9%
Hepatic Cirrhosis 1.9%
Prostate Cancer 1.9%
Protein Total Decreased 1.9%
Thrombosis Prophylaxis 1.9%
Bronchopneumonia 1.0%
Cerebral Haemorrhage 1.0%
Blood Beta-d-glucan Increased 12.5%
C-reactive Protein Increased 12.5%
Hyperthermia 12.5%
Hepatitis C Rna Positive 8.9%
Paralysis 8.9%
Tachycardia 8.9%
Death 3.6%
Hyperhidrosis 3.6%
Hypersensitivity 3.6%
Meningitis 3.6%
Pyrexia 3.6%
Respiratory Distress 3.6%
Blood Pressure Fluctuation 1.8%
Dyspnoea 1.8%
Eating Disorder 1.8%
Oxygen Saturation Decreased 1.8%
Poor Quality Drug Administered 1.8%
Pulmonary Oedema 1.8%
Sepsis 1.8%
Weight Decreased 1.8%

Drug Data